RECALL: Cancer-Causing Chemical in Blood Pressure Drugs

The U.S. Food and Drug Administration (FDA) has announced two lots of quinapril and hydrochlorothiazide tablets have been recalled due to the presence of nitrosamines. Nitrosamines, which make an appearance in food and water, may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

The drug is used to treat hypertension and lower blood pressure. The pink, round tablets contain 20 milligrams of quinapril and 12.5 milligrams of hydrochlorothiazide and are supplied in 90-count bottles with an expiration date of January 2023. 

The recalled batches # QE2021005-A and # QE2021010-A, were shipped to customers nationwide in May 2021.

DRUGRECALL

What should you do?

Medical questions can be directed to Aurobindo at 1-866-850-2876 or by email at pvg@aurobindousa.com.

Questions about the return of the recalled product can be addressed to Qualanex at 1-888-504-2014.

Adverse reactions or quality problems experienced with the use of the drug may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax at 1-800-FDA-0178.

source